PSC Collaboration Study- PROGRESS
C
Craig Lammert, MD
Primary Investigator
Enrolling By Invitation
18-100 years
All
Phase
N/A
2 Locations
Overview
Primary Sclerosing Cholangitis (PSC) is a chronic liver disease that lacks treatment options short of liver transplantation. This is secondary to rarity of the disease and poor understanding of the disease pathogenesis. We are participating in a multi-center study collecting PSC patients clinical and biological information along with genetic analysis in hope to discover potential gene candidates implicated in PSC.
Description
Primary Sclerosing Cholangitis (PSC) is a chronic liver disease that lacks treatment options short of liver transplantation. This is secondary to rarity of the disease and poor understanding of the disease pathogenesis. We are participating in a multi-center study collecting PSC patients clinical and biological information along with genetic analysis in hope to discover potential gene candidates implicated in PSC.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
PSC, Primary Sclerosing Cholangitis
-
Age: Between 18 Years - 100 Years
-
Gender: All
Updated on
15 May 2024.
Study ID: 1011004220
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
